The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Cancer Treatment Drugs-Global Market Insights and Sales Trends 2025

Cancer Treatment Drugs-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1816887

No of Pages : 120

Ask Your Query
Synopsis
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The global Cancer Treatment Drugs market size is expected to reach US$ 325040 million by 2029, growing at a CAGR of 8.8% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Treatment Drugs in various end use industries. The expanding demands from the Blood Cancer, Breast Cancer, Gastrointestinal Cancer and Prostate Cancer, are propelling Cancer Treatment Drugs market. Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Targeted Therapy segment is estimated at % CAGR for the next seven-year period.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Treatment Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Treatment Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Treatment Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Treatment Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Treatment Drugs covered in this report include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda and Eli Lilly, etc.
The global Cancer Treatment Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Global Cancer Treatment Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Treatment Drugs market, Segment by Type:
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Global Cancer Treatment Drugs market, by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cancer Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Cancer Treatment Drugs Market Overview
1.1 Cancer Treatment Drugs Product Overview
1.2 Cancer Treatment Drugs Market Segment by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy (Biologic Therapy)
1.2.5 Others
1.3 Global Cancer Treatment Drugs Market Size by Type
1.3.1 Global Cancer Treatment Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Cancer Treatment Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cancer Treatment Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cancer Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cancer Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cancer Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cancer Treatment Drugs Sales Breakdown by Type (2018-2023)
2 Global Cancer Treatment Drugs Market Competition by Company
2.1 Global Top Players by Cancer Treatment Drugs Sales (2018-2023)
2.2 Global Top Players by Cancer Treatment Drugs Revenue (2018-2023)
2.3 Global Top Players by Cancer Treatment Drugs Price (2018-2023)
2.4 Global Top Manufacturers Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Treatment Drugs Market Competitive Situation and Trends
2.5.1 Cancer Treatment Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Treatment Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Treatment Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Cancer Treatment Drugs Market
2.8 Key Manufacturers Cancer Treatment Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Treatment Drugs Status and Outlook by Region
3.1 Global Cancer Treatment Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cancer Treatment Drugs Historic Market Size by Region
3.2.1 Global Cancer Treatment Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Cancer Treatment Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Cancer Treatment Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cancer Treatment Drugs Forecasted Market Size by Region
3.3.1 Global Cancer Treatment Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Cancer Treatment Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Cancer Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cancer Treatment Drugs by Application
4.1 Cancer Treatment Drugs Market Segment by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Prostate Cancer
4.1.5 Respiratory or Lung Cancer
4.1.6 Others
4.2 Global Cancer Treatment Drugs Market Size by Application
4.2.1 Global Cancer Treatment Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Cancer Treatment Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cancer Treatment Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cancer Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cancer Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cancer Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cancer Treatment Drugs Sales Breakdown by Application (2018-2023)
5 North America Cancer Treatment Drugs by Country
5.1 North America Cancer Treatment Drugs Historic Market Size by Country
5.1.1 North America Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cancer Treatment Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Cancer Treatment Drugs Sales in Value by Country (2018-2023)
5.2 North America Cancer Treatment Drugs Forecasted Market Size by Country
5.2.1 North America Cancer Treatment Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Cancer Treatment Drugs Sales in Value by Country (2024-2029)
6 Europe Cancer Treatment Drugs by Country
6.1 Europe Cancer Treatment Drugs Historic Market Size by Country
6.1.1 Europe Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cancer Treatment Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Cancer Treatment Drugs Sales in Value by Country (2018-2023)
6.2 Europe Cancer Treatment Drugs Forecasted Market Size by Country
6.2.1 Europe Cancer Treatment Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Cancer Treatment Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Cancer Treatment Drugs by Region
7.1 Asia-Pacific Cancer Treatment Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cancer Treatment Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cancer Treatment Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cancer Treatment Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Treatment Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cancer Treatment Drugs Sales in Value by Region (2024-2029)
8 Latin America Cancer Treatment Drugs by Country
8.1 Latin America Cancer Treatment Drugs Historic Market Size by Country
8.1.1 Latin America Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cancer Treatment Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cancer Treatment Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Cancer Treatment Drugs Forecasted Market Size by Country
8.2.1 Latin America Cancer Treatment Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cancer Treatment Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Cancer Treatment Drugs by Country
9.1 Middle East and Africa Cancer Treatment Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cancer Treatment Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cancer Treatment Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cancer Treatment Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Treatment Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cancer Treatment Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Cancer Treatment Drugs Products Offered
10.1.5 Roche Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Cancer Treatment Drugs Products Offered
10.2.5 Novartis Recent Development
10.3 Celgene
10.3.1 Celgene Company Information
10.3.2 Celgene Introduction and Business Overview
10.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Celgene Cancer Treatment Drugs Products Offered
10.3.5 Celgene Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Amgen
10.5.1 Amgen Company Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Amgen Cancer Treatment Drugs Products Offered
10.5.5 Amgen Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Cancer Treatment Drugs Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Cancer Treatment Drugs Products Offered
10.7.5 Pfizer Recent Development
10.8 Takeda
10.8.1 Takeda Company Information
10.8.2 Takeda Introduction and Business Overview
10.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Takeda Cancer Treatment Drugs Products Offered
10.8.5 Takeda Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eli Lilly Cancer Treatment Drugs Products Offered
10.9.5 Eli Lilly Recent Development
10.10 AstraZeneca
10.10.1 AstraZeneca Company Information
10.10.2 AstraZeneca Introduction and Business Overview
10.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AstraZeneca Cancer Treatment Drugs Products Offered
10.10.5 AstraZeneca Recent Development
10.11 Astellas
10.11.1 Astellas Company Information
10.11.2 Astellas Introduction and Business Overview
10.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Astellas Cancer Treatment Drugs Products Offered
10.11.5 Astellas Recent Development
10.12 Merck & Co.
10.12.1 Merck & Co. Company Information
10.12.2 Merck & Co. Introduction and Business Overview
10.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Merck & Co. Cancer Treatment Drugs Products Offered
10.12.5 Merck & Co. Recent Development
10.13 Sanofi
10.13.1 Sanofi Company Information
10.13.2 Sanofi Introduction and Business Overview
10.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Sanofi Cancer Treatment Drugs Products Offered
10.13.5 Sanofi Recent Development
10.14 Bayer
10.14.1 Bayer Company Information
10.14.2 Bayer Introduction and Business Overview
10.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Bayer Cancer Treatment Drugs Products Offered
10.14.5 Bayer Recent Development
10.15 Biogen Idec
10.15.1 Biogen Idec Company Information
10.15.2 Biogen Idec Introduction and Business Overview
10.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Biogen Idec Cancer Treatment Drugs Products Offered
10.15.5 Biogen Idec Recent Development
10.16 Eisai
10.16.1 Eisai Company Information
10.16.2 Eisai Introduction and Business Overview
10.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Eisai Cancer Treatment Drugs Products Offered
10.16.5 Eisai Recent Development
10.17 Teva
10.17.1 Teva Company Information
10.17.2 Teva Introduction and Business Overview
10.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Teva Cancer Treatment Drugs Products Offered
10.17.5 Teva Recent Development
10.18 Otsuka
10.18.1 Otsuka Company Information
10.18.2 Otsuka Introduction and Business Overview
10.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Otsuka Cancer Treatment Drugs Products Offered
10.18.5 Otsuka Recent Development
10.19 Merck KGaA
10.19.1 Merck KGaA Company Information
10.19.2 Merck KGaA Introduction and Business Overview
10.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Merck KGaA Cancer Treatment Drugs Products Offered
10.19.5 Merck KGaA Recent Development
10.20 Ipsen
10.20.1 Ipsen Company Information
10.20.2 Ipsen Introduction and Business Overview
10.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Ipsen Cancer Treatment Drugs Products Offered
10.20.5 Ipsen Recent Development
10.21 AbbVie
10.21.1 AbbVie Company Information
10.21.2 AbbVie Introduction and Business Overview
10.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.21.4 AbbVie Cancer Treatment Drugs Products Offered
10.21.5 AbbVie Recent Development
10.22 Gilead Sciences
10.22.1 Gilead Sciences Company Information
10.22.2 Gilead Sciences Introduction and Business Overview
10.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Gilead Sciences Cancer Treatment Drugs Products Offered
10.22.5 Gilead Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Treatment Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Treatment Drugs Industrial Chain Analysis
11.4 Cancer Treatment Drugs Market Dynamics
11.4.1 Cancer Treatment Drugs Industry Trends
11.4.2 Cancer Treatment Drugs Market Drivers
11.4.3 Cancer Treatment Drugs Market Challenges
11.4.4 Cancer Treatment Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Treatment Drugs Distributors
12.3 Cancer Treatment Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock